Epidemiology of haemodialysis outcomes
Haemodialysis (HD) is the commonest form of kidney replacement therapy in the world,
accounting for approximately 69% of all kidney replacement therapy and 89% of all dialysis …
accounting for approximately 69% of all kidney replacement therapy and 89% of all dialysis …
Understanding development of malnutrition in hemodialysis patients: a narrative review
Hemodialysis (HD) majorly represents the global treatment option for patients with chronic
kidney disease stage 5, and, despite advances in dialysis technology, these patients face a …
kidney disease stage 5, and, despite advances in dialysis technology, these patients face a …
Outcomes of patients with end-stage kidney disease hospitalized with COVID-19
Given the high risk of infection-related mortality, patients with end-stage kidney disease
(ESKD) may be at increased risk with COVID-19. To assess this, we compared outcomes of …
(ESKD) may be at increased risk with COVID-19. To assess this, we compared outcomes of …
Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and …
More than 2 million people worldwide are being treated for end-stage kidney disease
(ESKD). This Series paper provides an overview of incidence, modality use (in-centre …
(ESKD). This Series paper provides an overview of incidence, modality use (in-centre …
Roxadustat for anemia in patients with end-stage renal disease incident to dialysis
R Provenzano, E Shutov, L Eremeeva… - Nephrology Dialysis …, 2021 - academic.oup.com
Background We evaluated the efficacy and safety of roxadustat versus epoetin alfa for the
treatment of chronic kidney disease-related anemia in patients new to dialysis. Methods …
treatment of chronic kidney disease-related anemia in patients new to dialysis. Methods …
[HTML][HTML] Guía clínica española del acceso vascular para hemodiálisis
Vascular access for haemodialysis is key in renal patients both due to its associated
morbidity and mortality and due to its impact on quality of life. The process, from the creation …
morbidity and mortality and due to its impact on quality of life. The process, from the creation …
The heart and vascular system in dialysis
C Wanner, K Amann, T Shoji - The Lancet, 2016 - thelancet.com
The heart and the vascular tree undergo major structural and functional changes when
kidney function declines and renal replacement therapy is required. The many …
kidney function declines and renal replacement therapy is required. The many …
Trends in US vascular access use, patient preferences, and related practices: an update from the US DOPPS practice monitor with international comparisons
RL Pisoni, L Zepel, FK Port, BM Robinson - American Journal of Kidney …, 2015 - Elsevier
Background Since the bundled end-stage renal disease prospective payment system began
in 2011 in the United States, some hemodialysis practices have changed substantially …
in 2011 in the United States, some hemodialysis practices have changed substantially …
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure
Patients with chronic kidney failure—defined as a glomerular filtration rate persistently below
15 mL/min per 1· 73 m 2—have an unacceptably high mortality rate. In developing countries …
15 mL/min per 1· 73 m 2—have an unacceptably high mortality rate. In developing countries …
[HTML][HTML] Worldwide, mortality risk is high soon after initiation of hemodialysis
BM Robinson, J Zhang, H Morgenstern, BD Bradbury… - Kidney international, 2014 - Elsevier
Mortality rates for maintenance hemodialysis patients are much higher than the general
population and are even greater soon after starting dialysis. Here we analyzed mortality …
population and are even greater soon after starting dialysis. Here we analyzed mortality …